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Identification of Human Rap1: Implications for
Telomere Evolution
Bibo Li, Stephanie Oestreich,†
and Titia de Lange*
The Rockefeller University
New York, New York 10021

Summary
It has been puzzling that mammalian telomeric proteins, including TRF1, TRF2, tankyrase, and TIN2 have
no recognized orthologs in budding yeast. Here, we
describe a human protein, hRap1, that is an ortholog
of the yeast telomeric protein, scRap1p. hRap1 has
three conserved sequence motifs in common with
scRap1, is located at telomeres, and affects telomere
length. However, while scRap1 binds telomeric DNA
directly, hRap1 is recruited to telomeres by TRF2. Extending the comparison of telomeric proteins to fission
yeast, we identify S. pombe Taz1 as a TRF ortholog,
indicating that TRFs are conserved at eukaryotic telomeres. The data suggest that ancestral telomeres, like
those of vertebrates, contained a TRF-like protein as
well as Rap1. We propose that budding yeast preserved Rap1 at telomeres but lost the TRF component,
possibly concomitant with a change in the telomeric
repeat sequence.
Introduction
The protection and maintenance of human chromosome
ends requires the function of two related factors, TRF1
and TRF2, which bind to the duplex telomeric TTAGGG
repeat array (Chong et al., 1995; Bilaud et al., 1997;
Broccoli et al., 1997). Inhibition of TRF2 in cultured cells
results in immediate deprotection of chromosome ends
as evident from the loss of the 3⬘ telomeric overhang
and appearance of covalently fused telomeres (van
Steensel et al., 1998; A. Smogorzewska and T. d. L.,
unpublished data). Compromised TRF2 function also
leads to cell cycle arrest, ATM/p53-mediated apoptosis,
and, in some cells, a senescence-like phenotype (van
Steensel et al., 1998; Karlseder et al., 1999). Truncated
forms of TRF1 and its interacting partner, TIN2, induce
inappropriate telomere elongation in telomerase expressing cells (van Steensel and de Lange, 1997; Kim
et al., 1999; Smogorzewska et al., 2000); overexpression
of full-length TRF1 and TRF2 results in gradual telomeric
decline (van Steensel and de Lange, 1997; Smogorzewska et al., 2000).
Although certain parallels between mammalian and
yeast telomere function can be drawn, it has been puzzling that there is no ortholog of TRF1 and TRF2 at
* To whom correspondence should be addressed (e-mail: delange@
rockvax.rockefeller.edu).
† Present address: Department of Molecular Biology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114.

telomeres in budding yeast. Similarly, TIN2 and tankyrase, proteins associated with mammalian telomeres
through their interaction with TRF1, have no recognized
orthologs in yeast (Smith et al., 1998; Kim et al., 1999).
Inversely, orthologs of a number of budding yeast telomeric proteins (for instance, Sir3p, Sir4p, Rif1p, Rif2p,
Cdc13p, Stn1p, and Tel2p) have not been identified in
mammals, although complete genome information will
be required to settle this issue. The telomerase reverse
transcriptase, Est2p, represents a striking exception to
this theme, being obviously homologous to the human
hTERT protein (Lendvay et al., 1996; Lingner et al., 1997;
Nakamura et al., 1997). However, human orthologs of
other yeast telomerase components, such as Est1p
(Lundblad and Szostak, 1989) and Est3p (Lendvay et
al., 1996), have not been found so far.
The lack of sequence similarity between the vertebrate TRF proteins and the yeast telomeric protein
scRap1p (Shore and Nasmyth, 1987) is particularly striking given that both are duplex telomeric DNA binding
factors and both act as negative regulators of telomere
length (Kyrion et al., 1992; Marcand et al., 1997; van
Steensel and de Lange, 1997; Smogorzewska et al.,
2000). Rap1p is the major telomeric DNA binding activity
in yeast (Buchman et al., 1988; Klein et al., 1992) and
every chromosome end in yeast contains ⵑ20 highaffinity Rap1p binding sites within its irregular TG1–3
telomeric repeat tract (Wang et al., 1990; Gilson et al.,
1993). Additional Rap1p binding sites occur upstream
of genes for many ribosomal proteins and glycolytic
enzymes (for review, see Buchman et al., 1988; Capieaux
et al., 1989), and Rap1p contributes to the regulation of
these genes through a transcriptional activation domain
located just C-terminal to its DNA binding domain (Hardy
et al., 1992a). However, based on indirect immunofluorescence, Rap1p is concentrated at telomeres (Klein et
al., 1992) and the telomeric function of Rap1p is better
understood than its role in transcriptional regulation.
Rap1p acts at telomeres by tethering two sets of proteins, the Sir proteins (Sir3p and Sir4p) (Moretti et al.,
1994; Cockell et al., 1995; Liu and Lustig, 1996) and
the Rif proteins (Rif1p and Rif2p) (Hardy et al., 1992b;
Wotton and Shore, 1997). Recruitment of the Sirs to
telomeres mediates the transcriptional repression of
subtelomeric genes, whereas the Rifs control telomere
length. Each of these four proteins binds to the C terminus of Rap1p, and tethering of this domain to telomeres
in themselves can result in resetting of telomere length
(Marcand et al., 1997). A second putative protein interaction domain, the BRCT (BRCA1 C-terminal) domain, was
recognized in the N terminus of scRap1p based on sequence comparison (Bork et al., 1997; Callebaut and
Mornon, 1997), but this part of scRap1p has yet to be
ascribed a function.
It was previously noted that scRap1p, like TRF1 and
TRF2, binds telomeric DNA with two Myb-type helixturn-helix motifs (Chong et al., 1995; Konig et al., 1996;
Bianchi et al., 1997, 1999; Smith and de Lange, 1997).
However, this shared DNA binding mode is achieved
using substantially different strategies. In scRap1p, two
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DNA binding modules are positioned in tandem in the
middle of the polypeptide, while TRF1 and TRF2 each
contain a single C-terminal Myb domain and use homodimerization to place two Myb domains on DNA (Bianchi
et al., 1997, 1999; Broccoli et al., 1997). As a consequence of their different architecture, TRF1 and
scRap1p recognize telomeric DNA in different ways. The
two Myb domains of scRap1p recognize two tandem
GGTGT sites at 8 bp distance (Konig et al., 1996), a
sequence arrangement frequently represented in the
yeast telomeric TG1–3 repeat tracts. The two Myb domains in the TRF1 dimer, by contrast, interact with their
YTAGGGTTR half sites regardless of their relative orientation and distance, as if the Myb domains are tethered
by unusually flexible linkers (Bianchi et al., 1999). A Mybtype DNA binding domain is also present in the S. pombe
protein Taz1, another telomeric protein that functions
as a negative regulator of telomere length, but no other
overt sequence similarity to the TRFs or Rap1p was
recognized (Cooper et al., 1997; Vassetzky et al., 1999;
Spink et al., 2000).
A search for TRF2-interacting proteins has revealed
a novel human telomeric protein with a role in telomere
length regulation that has significant sequence identity
(24%–25%) with scRap1p in three different domains.
Since this human protein has both structural and functional similarity to yeast Rap1p, we refer to it as hRap1.
In the context of the identification of human Rap1, we
reexamined the structural similarities of the telomeric
protein complex in S. cerevisiae, S. pombe, and vertebrates, revealing previously unappreciated relationships
and suggesting a model for the evolution of eukaryotic
telomeres.
Results
A TRF2-Interacting Protein with Sequence
Similarity to Yeast Rap1p
A standard yeast two-hybrid screen of HeLa cDNAs with
part of the human TRF2 protein as bait yielded a partial
1.35 kb cDNA clone (referred to as M50–27) that was
used to isolate a 2.67 kb cDNA (Figure 1A). This cDNA
appears to represent the full-length mRNA which is detectable as an ⵑ2.5 kb species with a ubiquitous expression pattern (Figure 1B). The open reading frame in this
cDNA predicts a 399 aa protein of ⵑ47 kDa and a Profile
Scan motif search revealed that the ORF contained an
N-terminal BRCT domain and a central Myb-type helixturn-helix motif. The ORF also predicted an acidic C
terminus (aa 214–382, pI around 3.8) featuring a predicted 33 aa coiled–coil region and a bipartite NLS (Figures 1A and 1C). Since yeast Rap1p has an N-terminal
BRCT domain (Bork et al., 1997; Callebaut and Mornon,
1997), central Myb domains (Konig et al., 1996), and an
acidic C terminus, we examined the sequence similarity
of the TRF2-interacting protein and Rap1p in more detail. Alignments revealed an additional region of sequence similarity in the C termini of the human and yeast
proteins that coincides with the main protein–protein
interaction domain of scRap1p (Hardy et al., 1992b; Moretti et al., 1994; Cockell et al., 1995; Liu and Lustig, 1996;
Wotton and Shore, 1997) (Figure 1F). Thus, the TRF2interacting protein has three domains in common with

Rap1p, including a region unique to Rap1p, suggesting
that it is a human ortholog of Rap1p. We therefore refer
to this protein as hRap1.
The BRCT domain is an ⵑ95 aa presumed protein–
protein interaction motif first found in BRCA1, p53BP1,
and Rad9p (Koonin et al., 1996) and now recognized in
a large number of other proteins linked to DNA repair
(Bork et al., 1997; Callebaut and Mornon, 1997). X-ray
crystallography of the XRCC1 second BRCT domains
revealed an autonomously folded domain composed of
a four-stranded parallel ␤ sheet surrounded by three ␣
helices (Zhang et al., 1998). Although the BRCT domains
of the three Rap1p orthologs are highly diverged, most
of the conserved patches of hydrophobic residues can
be recognized by alignment to the BRCT domains of
XRCC1 (Figure 1D).
Yeast Rap1p contains two HTH DNA binding domains
as revealed by structural analysis (Konig et al., 1996).
The first of these domains (called R1) can be recognized
as a Myb motif in sequence alignments, although it is
highly diverged from the Myb consensus sequence (Larson et al., 1994; Lipsick, 1996; Konig and Rhodes, 1997).
ScRap1p R1 has some notable peculiarities, including
a long linker between helix 1 and helix 2, and the presence of phenylalanine and tyrosine residues instead of
the three highly conserved tryptophan residues typical
of Myb domains (Konig et al., 1996; Konig and Rhodes,
1997). Similarly, the hRap1 Myb motif has phenylalanine
and tyrosine at two of the three tryptophan positions
and it carries an insert of ⵑ10 aa between helix 1 and 2,
consistent with a close relationship between the human
and yeast Rap1 genes (Figure 1E). Furthermore, the Myb
domains of human and yeast Rap1 both lack the conserved glycine just beyond helix 1 and they do not have
a patch of aliphatic residues beyond helix 2. Finally,
both human and yeast Rap1 have a histidine residue at
the position of the highly conserved arginine preceding
helix 3. In order to examine the relationship between
several relevant Myb domains, we removed the variable
spacers between the ␣ helices that can bias sequence
comparisons to favor similarly sized polypeptides. The
resulting alignment underscores a stronger similarity of
the human and yeast Rap1 Myb domains compared to
the Myb domains of TRF1, the S. pombe Taz1, and S.
cerevisiae Tbf1, each of which are more closely related
to R1/R2 of c-Myb. It was previously pointed out that
the Myb domains of the TRF/Taz/Tbf group show certain
similarities in their recognition helix (helix 3) (Bilaud et
al., 1996), and some of these (notably the motif LKD)
are also present in hRap1. However, the Myb domains
of human and yeast Rap1 are clearly more closely related to each other than to the Myb domains of the TRF/
Taz1/Tbf1 group.
The C-terminal quarter of scRap1p can be divided
into a transactivation domain of about 65 aa and a more
terminal domain (sometimes referred to as silencing domain, SD) that confers telomeric silencing and length
regulation (Hardy et al., 1992a; Kyrion et al., 1992, 1993;
Liu et al., 1994; Buck and Shore, 1995; Liu and Lustig,
1996). This part of Rap1p binds Rif1p and Rif2p and
interacts with Sir3p and Sir4p (Hardy et al., 1992b; Moretti et al., 1994; Cockell et al., 1995; Liu and Lustig, 1996;
Wotton and Shore, 1997). Alignment of hRap1 with the
C terminus of scRap1p reveals significant sequence
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Figure 1. Sequence and Expression of the Human Ortholog of Yeast Rap1p
(A) Domain structure of hRap1. BRCT, BRCA1 C terminus; Myb, Myb-related HTH motif; Coil, predicted coiled domain; RCT, homology to the
Rap1p C terminus; NLS, nuclear localization signal. The original two-hybrid clone and peptides used for raising antibodies are indicated.
(B) Ubiquitous expression of hRap1 mRNA. Northern blot (Clontech) probed with the original hRap1 two-hybrid clone or ␤-actin. Lane 1,
spleen; lane 2, thymus; lane 3, prostate; lane 4, testis; lane 5, ovary; lane 6, small intestine; lane 7, colon (mucosal lining); lane 8, peripheral
blood leukocytes.
(C) Amino acid sequence of hRap1. The BRCT, Myb, Coil, and RCT domains are colored as in (A). The putative NLS is shown in bold.
(D) Alignment of BRCT domains in hRap1 and several other proteins based on the XRCC1 BRCT structure (Bork et al., 1997; Zhang et al.,
1998). Four ␤ sheets (red arrows) and three ␣ helices (blue bars) are marked. Bold residues are highly conserved (Bork et al., 1997), and other
sequence similarities (Kyte-Doolittle) are shaded.
(E) Alignment of the Myb domains of Rap1 with human c-Myb R2, TRF1, spTaz1, and scTbf1p using ClustalW. The position of three ␣ helices
in c-Myb (Ogata et al., 1994) are indicated. Omitted amino acids between the ␣ helices are indicated in parentheses. The three most conserved
tryptophans are in bold. Shaded residues highlight sequence similarities (Kyte-Doolittle).
(F) Alignment of the C-terminal region of three Rap1 proteins using ClustalW. Green shading highlights sequence similarities in the RCT domain
(represented by the C-terminal 108 aa of hRap1). Identities in all three Rap1s are in bold. The most conserved 52 aa are underlined. The
boxed region indicates the C-terminal tail domain of scRap1p (Liu and Lustig, 1996).
(G) Overview of the sequence similarities in three Rap1 proteins listing percentage identities (black) and similarities (gray) in each pair-wise
comparison.

similarity in the final 108 aa of these proteins (Figure
1F), which we refer to as the Rap1 C Terminus (RCT)
domain. The highest level of conservation is found in
the final 52 aa where there is 30% identity between
human and scRap1p and 49% identity between the
Rap1p proteins from K. lactis and S. cerevisiae (Figure
1F). Although its structure is not yet known, this part of
the Rap1 proteins is likely to have an identical fold.
An overall summary of the similarities between the

human and yeast Rap1 proteins is given in Figure 1G.
We have not found significant similarity between human
and yeast Rap1p outside the three domains mentioned
above. Notably, the trans-activation domain of yeast
Rap1p is not represented as such in hRap1p. This region, positioned between the Myb domain and the RCT
domain, is not conserved in sequence and hRap1 has
a predicted coiled domain that is not present in the
yeast Rap1ps. Furthermore, we were unable to detect
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The TRF2-interacting domain in hRap1 was mapped
to the C terminus (Figure 2C). The RCT domain in
scRap1p is required for interaction with Rif1p, Rif2p,
Sir3p, and Sir4p (Hardy et al., 1992b; Moretti et al., 1994;
Cockell et al., 1995; Liu and Lustig, 1996; Wotton and
Shore, 1997). Similarly, deletion mapping indicated that
a region between aa 267 and 372 in the C terminus of
hRap1 is responsible for the binding to TRF2 (Figure
2C). Yeast two-hybrid experiments also suggested homotypic interactions in the RCT domain. The area required
for homotypic interactions in hRap1 is more extensive
than that needed for binding to TRF2 and requires sequences from aa 267 to the very C terminus of the protein, including the last 27 aa (Figure 2D). The final 8 aa
of the scRap1p RCT domain have been shown to be
required for the interaction with Sir3p (Liu and Lustig,
1996). Consistent with the detection of homotypic interactions in the yeast two-hybrid assay, recombinant
hRap1 behaves as a dimer in gel-filtration chromatography (D. Rhodes, personal communication). A summary
of all the interaction data is given in Figure 2E.

Figure 2. Two-Hybrid Mapping of hRap1–TRF2 and hRap1–hRap1
Interacting Domains
(A) Mapping the hRap1-interacting domain in TRF2. (B) hRap1 does
not interact with TRF1. (C) Mapping the TRF2-interacting domain in
hRap1. (D) hRap1 can interact with itself through the RCT domain.
(E) Summary of the TRF2-hRap1 interactions. Constructs on the left
in (A, B, and D) and constructions on the right in (C) show LexA
fusions. No transactivation activity was detected for all LexA-hRap1
fusion proteins. Constructs on the right in (A, B, and D) and constructions on the left in (C) represent GAD fusions. ␤-galactosidase levels
(right column) were measured as described in the Experimental
Procedures. The values represent an average of three independent
transformants. Values ⬍0.05 are indicated as 0.

transactivation with this or other parts of hRap1 in a
LexA fusion context (see below, Figure 2D).
The C Terminus of hRap1 Is a Protein
Interaction Domain
The yeast two-hybrid system was used to delineate the
regions in TRF2 and hRap1 responsible for their interaction. Deletion mapping indicated that hRap1 associated
with a central domain of TRF2 located between positions
123 and 366 (Figure 2A). Although TRF2 and TRF1 show
significant sequence similarity in the N-terminal half of
this region (ⵑ29% in the region from aa 45 to 245 in
TRF2 [Broccoli et al., 1997]), hRap1 does not interact
with full-length TRF1 in a two-hybrid setting (Figure 2B).

TRF2 Recruits hRap1 to Telomeres
The subcellular localization of hRap1 was examined by
indirect immunofluorescence (IF) of cultured human
cells (Figure 3). A polyclonal rabbit antibody (Ab 765)
was raised against [His]6-tagged hRap1 expressed in a
baculovirus system and subjected to affinity purification. This reagent revealed a prominent punctate nuclear
pattern in several different human cell lines (HeLa cervical carcinoma, HT1080 fibrosarcoma cells, and IMR90
primary fibroblasts) (Figures 3A and 3D and data not
shown). The same telomeric pattern was seen in interphase nuclei stained with an hRap1-specific, affinitypurified, anti-peptide antibody (Ab 666 directed against
aa 211–235, see Figure 1A) (Figure 3G), and exogenously
expressed FLAG-tagged hRap1 also localized to telomeres (data not shown). Dual IF with antibodies for TRF1
showed that the majority of hRap1 colocalized with
TRF1 in interphase nuclei (Figures 3A–3C). Since it was
previously shown that TRF1 is found exclusively at sites
of telomeric TTAGGG repeats (Chong et al., 1995), the
colocalization of hRap1 with TRF1 indicated that hRap1
is predominantly located at telomeres. Similarly, hRap1
colocalized with TRF2 in all cells examined (Figures 3D–
3F). The telomeric localization of hRap1 is further corroborated by IF analysis of metaphase chromosomes
which showed an exclusively terminal signal with hRap1
Ab 666 (Figure 3J). We surmise from these data that, as
in yeast, human Rap1 is concentrated at telomeric loci
throughout the cell cycle.
We next asked whether the accumulation of hRap1
at telomeres depended on its interaction with TRF2, as
suggested by the two-hybrid interaction of these proteins and their coimmunoprecipitation (X.-D. Zhu et al.,
submitted). To this end, we examined HeLa cells which
were transiently transfected with the dominant-negative
allele of TRF2 (TRF2⌬B⌬M), a truncated version of TRF2
that forms inactive heterodimers with the endogenous
protein and effectively removes TRF2 from telomeres
(van Steensel et al., 1998). HeLa cells transfected with
this construct were examined by IF for the presence of
TRF2 on telomeres after gentle extraction with Triton
X-100 to remove the nucleoplasmic proteins. A subpopulation of the cells showed a severe loss of the punctate
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Figure 3. hRap1 Locates to Telomeres through
Interaction with TRF2
(A and D) Localization of endogenous hRap1
using indirect immunofluorescence with antibody 765 (green) in interphase nuclei of
HeLaI.2.11 cells. (B) Localization of TRF1 in
the same cells as in (A) using mouse antibody
against TRF1 (red). (C) is a superimposition
of (A) and (B). (E) Localization of TRF2 in the
same cells as in (D) using mouse antibody
against TRF2 (red). This antibody shows
some staining at nontelomeric sites. (F) is a
superimposition of (D) and (E). (G) Localization of endogenous hRap1 using antibody
666 (red) in interphase nuclei of HeLaI.2.11
cells transiently transfected with TRF2⌬B⌬M.
The cells were extracted with Triton X-100
before fixation. (H) Localization of TRF2 in the
same cells as in (G) using mouse antibody
against TRF2 (green). (I) is a superimposition
of (G) and (H). (J) Localization of endogenous
hRap1 using antibody 666 (green) on metaphase chromosomes in HeLaI.2.11 cells. DNA
was stained with DAPI (blue). Bars in (C), (F),
(I), and (J) represent 5 m.

TRF2 pattern, as expected from previous results with
the TRF2⌬B⌬M allele (van Steensel et al., 1998) (Figure
3H). In dual IF experiments for both TRF2 and hRap1,
we found a close correlation between the accumulation
of the two proteins in a punctate pattern (Figures 3G–3I).
Specifically, all cells that had retained TRF2 at telomeres
showed hRap1 at the same sites whereas cells that
had lost the punctate TRF2 pattern (presumably due to
expression of the TRF2⌬B⌬M allele) also lacked hRap1
dots. Based on these data, interaction with TRF2 appears to be the predominant manner by which hRap1
accumulates on telomeres. In agreement, telomeric accumulation was observed with a C-terminal fragment of
hRap1 (aa 184 to the C terminus) which retains the TRF2
interacting domain, but lacks the BRCT and Myb domains (data not shown).
TRF2 and hRap1 Form a Complex
on Telomeric DNA
Since hRap1 carries a Myb motif, it was pertinent to
examine its interaction with DNA. Using a doublestranded [TTAGGG]12 probe and a bandshift assay that
allows binding of TRF2 to this probe, we failed to detect
a protein–DNA complex with baculovirus-expressed

hRap1 (Figure 4A). Although a large number of parameters were varied in additional experiments (for instance,
gel conditions, reaction buffer, and protein preparations), we did not find evidence for the binding of telomeric repeat DNA by hRap1. We also failed to detect a
complex of hRap1 with single-stranded telomeric DNA
or with duplex probes containing the yeast telomeric
TG1–3 repeats (data not shown).
When hRap1 was incubated with TRF2 and a
ds[TTAGGG]12 probe, a ternary complex was formed
(Figure 4B). Titration of TRF2 on DNA resulted in two
complexes with different mobility (Figures 4A and 4B).
The slower migrating complex appeared only at high
protein concentrations and presumably represents a
complex containing a larger number of DNA-bound
TRF2 molecules. When hRap1 was added to the reaction, we observed an additional complex that migrated
above the two TRF2 complexes (Figure 4B). The appearance of this new band was strictly dependent on the
addition of hRap1 and was not observed in bandshift
reactions with hRap1 and TRF1 (data not shown). A
supershift assay with an affinity-purified, anti-peptide
antibody directed to aa 283 to 307 of hRap1 (Ab 664,
see Figure 1A) demonstrated that the hRap1-dependent
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Figure 4. hRap1 Binds to TRF2-Telomeric
DNA Complexes
(A) Lack of telomeric DNA binding activity for
hRap1. Bandshift assays with hRap1 and a
ds(TTAGGG)12 probe. The highest concentration of hRap1 is 20 pM and the dilution series
represents 3-fold steps. Lane 1 represents
reaction with 1 pM TRF2. (B) hRap1 and
hTRF2 form a ternary complex. Bandshift assays with increasing amounts of TRF2 (lanes 2 to 6, 3-fold steps up to 20 pM) or TRF2 and hRap1 protein (lanes 1 and 7, 2 pM of each
protein). (C) The TRF2/hRap1 specific complex can be super-shifted by antibodies against hRap1. Bandshift assays with ⵑ2 pM of TRF2 and
hRap1 and antibodies to hRap1 (Ab 664) and tankyrase (Ab 465) as indicated above the lanes. Lanes 4, 7, 8, and 9 contain 250 ng of antibody.
Lane 5 contains 50 ng of antibody. Small arrows, TRF2 complex. Large arrows, hRap1-TRF2 complex.

bandshift complex indeed contained hRap1 protein (Figure 4C). An antibody to the TRF1-interacting protein,
tankyrase (Ab 465), served as a negative control in this
experiment (Figure 4C). These data are consistent with
the observation that hRap1 binds to telomeres in a
TRF2-dependent manner.
Although hRap1 does not appear to bind DNA by itself,
we considered the possibility that hRap1 might interact
with DNA in the context of the TRF2 complex. Such
additional protein–DNA contacts often result in cooperative binding. An example is the interaction of two DNA
binding proteins, Mcm1 and ␣2, which bind to each
other on certain yeast operators, and display strong
cooperative effects (⬎10-fold enhancement) in bandshift assays with the appropriate target DNAs (Keleher
et al., 1989; Smith and Johnson, 1992). However, we
failed to detect significant cooperativity for TRF2 and
hRap1 under the conditions that allow detection of the
ternary complex. No enhanced binding was detectable
when hRap1 was added to TRF2 band-shift reactions
(for instance, compare lanes 4 and 7 in Figure 4B and
lanes 2 and 3 in Figure 4C). In addition, we failed to
detect an effect of hRap1 on the off-rate of the complexes (data not shown). We note that in some cases,
additional protein DNA contacts are known to have a
relatively minor cooperative effect. For instance, the
binding of the second Myb domain in TRF1 homodimers
only increases the affinity by a factor of 10 (Bianchi
et al., 1999). Footprinting analysis of the TRF2-hRap1
complex might provide further insight into this issue.
hRap1 Affects Telomere Length
ScRap1p has two well-defined functions at yeast telomeres. First, scRap1p recruits Sir3p and Sir4p to telomeres, resulting in the establishment of a heterochromatic state that represses the expression of nearby
genes (Moretti et al., 1994; Cockell et al., 1995; Liu and
Lustig, 1996 ). Because we and others have failed to
demonstrate telomeric silencing in human cells (Broccoli and Cooke, 1994; H. Tommerup and T. d. L., unpublished data), exploration of this potential role for hRap1
is currently not possible. The second known function
of scRap1p at chromosome ends is the regulation of
telomere length (Conrad et al., 1990; Lustig et al., 1990;
Kyrion et al., 1992; Liu et al., 1994; Marcand et al., 1997).
Tethering experiments have demonstrated that cells
evaluate telomere length based on the number of
scRap1p C-terminal domains present at chromosome
ends (Marcand et al., 1997). The current “protein-counting” model for telomere length homeostasis dictates

that long telomeres recruit a greater number of Rap1p
molecules, resulting in inhibition of telomere extension
in cis. How the C terminus of Rap1p regulates telomere
elongation has not been clarified, but, the relevant part
of Rap1p interacts with two proteins, Rif1 and Rif2, each
of which contributes to telomere length homeostasis
(Hardy et al., 1992b; Wotton and Shore, 1997).
In order to explore a function for hRap1 in telomere
length regulation, we used a previously developed Tetracyclin (Doxycyclin)-inducible system in the human fibrosarcoma cell line HTC75 (an HT1080 derivative) (van
Steensel and de Lange, 1997). HTC75 cells express high
levels of telomerase, yet maintain their telomeres at a
stable length setting over long periods of growth (300
population doublings [PD]). The stable length setting
of HTC75 telomeres depends on TRF1 and TRF2 (van
Steensel and de Lange, 1997; Smogorzewska et al.,
2000). Overexpression of TRF1 or TRF2 results in gradual telomeric decline although telomerase levels are unaffected.
We derived five independent clonal HTC75 cell lines
(F9, F11, F13, F14, and F17) overexpressing full-length,
FLAG-tagged hRap1 in an inducible manner. In each
cell line, Western analysis demonstrated inducible expression of an hRap1 protein that appeared slightly
larger than endogenous hRap1, as expected from the
presence of the FLAG tag (Figure 5A). Induction of hRap1
in these cell lines did not affect the expression of endogenous hRap1 (Figure 5A) or other telomeric proteins
(including TRF1, TRF2, and tankyrase) or telomerase
activity (data not shown).
The effect of hRap1 on telomere length homeostasis
was determined by measuring telomere length changes
during prolonged culturing of the cells. A control cell
line (B31) transfected with the empty vector displayed
no changes in telomere length in the presence or absence of doxycyclin (Figure 5B). Of five hRap1 expressing lines, one (F11) showed erratic telomere length
changes under uninduced conditions and was not studied further. The other cell lines showed consistent
changes in telomere dynamics, in each case demonstrable as a gradual elongation in the mean length of the
telomeric restriction fragments (Figures 5C–5E and data
not shown). The growth of the telomeres was largely
dependent on the induction of hRap1 expression, although leaky expression of hRap1 under repressed conditions may have led to gradual telomere extension in
the lines F9 and F13. The maximum telomere elongation
rate in cells overexpressing hRap1 was 40–50 bp/PD
(based on the early stages of the F9 and F17 growth
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Figure 5. Overexpression of Full-Length hRap1 Results in Telomere Elongation
(A) Western analysis of the inducible expression of the FLAG-tagged hRap1 in three F cell lines. Extracts were prepared from cells grown in
parallel in the presence (uninduced) or absence (induced) of doxycyclin for four population doublings and probed with the hRap1 antibody
765 that detects both the endogenous hRap1 and the induced, FLAG-tagged hRap1.
(B) Telomere length is maintained stably in clonal HTC75 line B31 containing empty expressing vector pUHD10–3. Chart showing the median
telomere lengths versus PD in cells grown under induced (⫹) or uninduced (⫺) conditions.
(C–E) Time course of changes in telomere length in clonal HTC75 lines expressing FLAG-tagged hRap1 (F9 in C, F17 in D, and F13 in E) grown
in the absence and presence of doxycyclin (⫹ and ⫺ induction, respectively). Top, genomic blotting analysis of telomeric restriction fragments
in HinfI/RsaI digested DNA, probed with a TTAGGG repeat probe. Bottom, chart showing the changes of median telomere lengths in each
corresponding cell line.

curves). Telomere growth occurred at a rate of 30 bp/
PD in F14 (data not shown). However, much more modest rates of telomere elongation were found in F13,
which showed extension at a rate of 17 bp/PD (Figure
5E). Similar clonal variations in response were previously
observed with HTC75 clones expressing TRF1 (van
Steensel and de Lange, 1997).
Taz1 Is a Member of the TRF Protein Family
Prompted by the identification of the ortholog of yeast
Rap1p at human telomeres, we examined the possibility
of other such relationships. Taz1 was identified in S.
pombe by a one-hybrid screen using telomeric DNA and
also by a screen for loss of telomeric silencing (Cooper
et al., 1997; Nimmo et al., 1998). The ORF of Taz1 showed
a Myb domain near the C terminus but no other sequence similarity to TRFs or Rap1p had been recognized. The identification of the key sequences conserved in scRap1 and hRap1 showed that Taz1, which
lacks the BRCT and the RCT domains, is not a member
of this family.
TRF1 and TRF2 have been identified in mice and humans and sequence alignments have shown that in addition to their C-terminal Myb motif, the TRFs have a defining sequence motif near their N termini. This domain,
called TRF homology (TRFH) domain here, is a region
of ⵑ200 aa with unknown function, although it overlaps

with protein–protein interaction domains in both TRF1
and TRF2 (Bianchi et al., 1997; Broccoli et al., 1997; Kim
et al., 1999). The mammalian TRFs have approximately
29% sequence identity in this region (Broccoli et al.,
1997; Smith and de Lange, 1997). Alignment of Taz1
with this part of TRF1 and TRF2 revealed significant
similarity to this central domain (Figure 6A). Using standard ClustalW settings, Taz1 can be aligned to TRF1
yielding 24% sequence identity and 47% similarity over
180 aa (Figures 6A and 6B).
Thus, Taz1 has two sequence motifs in common with
TRF1 and TRF2: a Myb domain that is substantially more
similar to that of the TRFs than to scRap1p R1 (Figure
1E) and the TRFH domain (Figure 6A). Furthermore, the
overall architecture of Taz1 seems to resemble that of
the TRFs since each of these proteins bind to DNA as
a homodimer (Bianchi et al., 1997; Broccoli et al., 1997;
van Steensel et al., 1998; Spink et al., 2000 ). Finally,
Taz1, like the TRFs, acts as a negative regulator of telomere length (Cooper et al., 1997). Based on these structural and functional similarities, we suggest that Taz1 is
a member of the TRF family of telomeric proteins.
It is not clear whether Taz1 is more closely related to
TRF1 or to TRF2. Although the TRFH and Myb domains
of Taz1 are more similar to those of TRF1, the region
between the TRFH and the Myb domain bears more
similarity to TRF2. The TRF1 and TRF2 proteins are
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complex in S. cerevisiae evolved through a combination
of gene loss and nonorthologous gene displacement
and that these changes were accompanied by an alteration in the telomeric DNA sequence. Our findings may
allow a more meaningful comparison of telomere biology
in yeast, vertebrates, and other eukaryotes.

Figure 6. S. pombe Taz1 Is a Member of the TRF Family
(A) Alignment of the TRFH domain of mouse and human TRF1,
mouse and human TRF2, and S. pombe Taz1 using ClustalW. Identical residues are in bold; sequence similarities are shaded (KyteDoolittle).
(B) Overview of the sequence similarities in TRF and Taz1 proteins,
listing percentage identity (black) and similarity (gray).

paralogs with strikingly different N termini (Chong et al.,
1995; Broccoli et al., 1997). The first 45 aa of TRF2 are
very basic, while the N terminus of TRF1 is acidic. In
contrast, the N terminus of Taz1 has no overriding acidic
or basic nature.
Discussion
Proteins that bind to the duplex part of the telomeric
repeat array have been studied in vertebrates and in the
yeasts S. cerevisiae and S. pombe. The identification
of the human ortholog of the budding yeast telomeric
protein Rap1p now suggests an evolutionary relationship between the telomeric complexes in these three
systems. We propose that telomeres in vertebrates and
in S. pombe represent an ancestral situation in which a
TRF-like protein and a Rap1-like factor both functioned
at telomeres, whereas the arrangement found in S. cerevisiae is apparently different, representing telomeres
without the TRF module. We propose that the telomeric

Structural and Functional Similarities of Human
and Yeast Rap1
Human Rap1 has three domains in common with yeast
Rap1p. It contains a central Myb motif with specific
sequence features also present in the yeast Rap1p R1
Myb domain. In addition, human Rap1, like yeast Rap1p,
carries a BRCT domain at the N terminus and the Rap1
proteins share a conserved motif (the RCT domain) in
their C termini. Functionally, hRap1 also displays strong
similarities to scRap1p. Like the yeast protein, hRap1
is an integral component of the telomeric complex and
the majority of the protein is detectable at chromosome
ends by indirect immunofluorescence. Furthermore, in
both yeast and human Rap1, the C terminus of the protein functions to bind other telomeric proteins.
Yeast and human Rap1 may also be similar with regards to their effect on telomere maintenance. Yeast
Rap1p acts as a negative regulator of telomere length.
A number of rap1 mutants in yeast display telomere
elongation phenotypes (Kyrion et al., 1992; Liu et al.,
1994) and mutation of the Rap1p binding sites in yeast
telomeres can result in run-away telomere elongation
(McEachern and Blackburn, 1995; Krauskopf and Blackburn, 1996). Furthermore, the scRap1p-interacting factors, Rif1p and Rif2p, display characteristics consistent
with a negative regulatory pathway that limits telomere
elongation (Hardy et al., 1992b; Wotton and Shore,
1997). Since targeting the Rap1p C-terminal domain to
subtelomeric sites results in shortened telomeres (Marcand et al., 1997), it was suggested that Rap1p is a cisacting negative regulator of telomere maintenance and
that cells measure telomere length through counting
the number of Rap1p C-terminal domains at individual
chromosome ends.
Moderate overexpression of scRap1p results in slight
telomere elongation (Conrad et al., 1990), most likely
because the increased abundance of scRap1p titrates
a limiting component required for inhibition of telomere
extension (e.g., one of the Rif proteins). The phenotype
of overexpression of human Rap1 is very similar. Increased hRap1 level in the telomerase positive cell line
HTC75 resulted in a moderate telomere elongation. It is
possible that the mild telomere extension phenotype is
due to titration of an hRap1-interacting protein that is
required for stable telomere length maintenance. It will
be necessary to establish the effect of diminished hRap1
activity to settle this issue.
Although the hRap1-interacting partner TRF2 is required for the protection of chromosome ends (van
Steensel et al., 1998; Karlseder et al., 1999), it has yet
to be established whether hRap1 contributes to this
function. A possible role for yeast Rap1p in maintaining
telomere integrity is suggested by the instability of telomeres in rap1–17 cells (Kyrion et al., 1992). In addition,
overexpression of yeast Rap1p induces a mild chromosome instability phenotype (Conrad et al., 1990) and

Human Rap1
479

several rap1ts mutants have effects consistent with
scRap1p acting to protect chromosome ends (Lustig et
al., 1990). Like inhibition of TRF2, complete loss of
Rap1p in yeast is lethal but this phenotype may be primarily due to nontelomeric functions.
A BLAST search with full-length hRap1 against the
budding yeast genome did not yield scRap1p or
klRap1p. Similarly, a search with Taz1 yielded several
Myb motif proteins but not the TRFH domains of any of
the four mammalian TRFs represented in the nonredundant database. These findings illustrate current difficulties in finding highly diverged but biologically informative orthologs. Precise definition of the most conserved
motifs in the TRF and Rap1 families may facilitate the
identification of telomeric proteins in other organisms.
S. pombe Taz1 Is a Member of the TRF Family
We propose that Taz1 is a member of the TRF family of
duplex telomeric DNA binding proteins. This family is
defined by the presence of two regions of sequence
similarity: a Myb motif that is closely related to c-Myb
R1/R2 and a TRF homology domain. TRF family proteins
undergo homotypic interactions and bind telomeric DNA
as dimers or higher order oligomers (Bianchi et al., 1997;
Broccoli et al., 1997; Spink et al., 2000). In addition, each
of these proteins have a negative effect on telomere
length maintenance in telomerase expressing cells
(Cooper et al., 1997; van Steensel and de Lange, 1997;
Smogorzewska et al., 2000).
Taz1 has two additional functions. First, it suppresses
a telomerase-independent pathway of telomere maintenance, possibly by interfering with recombination at
telomeres (Nakamura et al., 1998). This function is reminiscent of the protective activity of TRF2, which appears
to suppress inappropriate DNA repair at mammalian
telomeres (van Steensel et al., 1998). Secondly, Taz1
plays a role in meiosis. Taz1 mutants display a defect
in the horse-tail stage of meiosis I in S. pombe (Cooper
et al., 1998; Nimmo et al., 1998), in which telomeres
associate with the spindle pole body and facilitate the
rapid migration of the meiotic nucleus through the cell
(Chikashige et al., 1994, 1997; Kohli, 1994). This telomere-led movement critically depends on Taz1, with
taz1⫺ cells showing loss of clustering of telomeres at
the spindle pole body and a marked drop in meiotic
recombination and spore viability. It will be of interest
to determine whether TRF1 or TRF2 has a role in mammalian meiosis, which features an analogous chromosome reorganization in the bouquet stage of meiosis I
(see for review de Lange, 1998).
Evolution of Eukaryotic Telomeres
The recognition of S. pombe Taz1 as a member of the
TRF family suggests that a TRF-like protein originally
was engaged on telomeres in the last common ancestor
of fungi and vertebrates. According to this view, S. cerevisiae most likely lost the TRF-like telomere binding
component at some point during the divergence of the
Hemi- and Eu-ascomycetes (represented in Figure 7B
by budding yeasts and Neurospora, respectively).
Given that human TRF2 facilitates the binding of
hRap1 to telomeres, this may have been one of the

Figure 7. Model for the Evolution of Eukaryotic Telomeres
(A) A model for the evolution of duplex telomeric DNA binding proteins. See Discussion for details. TRF/Taz1 and Rap1 proteins are
shown in the same corresponding shapes but different colors. Vertebrate telomeres have both Rap1 and a TRF module. The vertebrate
Rap1 is drawn as not touching DNA for the sake of simplicity. Actual
DNA contacts of hRap1 in vivo have not been analyzed. The S.
pombe ortholog of Rap1 has not been identified and its presence
at S.pombe telomeres is speculative. Loss of the TRF module is
proposed to have occurred in budding yeasts. The proposed structure of the telomeric complex in the last common ancestor of fungi
and vertebrates is shown to contain both a TRF-like protein as well
as a Rap1-like factor. No prediction is made on whether the original
Rap1 bound to telomeric DNA directly or via interaction with the
TRF tether.
(B) Preponderance of TTAGGG-like repeats at telomeres of most
eukaryotes with the exception of budding yeasts. For references on
telomeric sequences, see Henderson (1995). Abbreviated approximate lineage of eukaryotes is based on the phylogeny listed in http://
phylogeny.arizona.edu/tree/life.html. Line lengths do not represent
evolutionary distances.

original functions of the ancestral TRF (Figure 7A). Thus,
it is possible that Taz1 also recruits a Rap1 to telomeres.
Complete genome information on S. pombe may reveal
the existence of a Rap1 ortholog. It will be of interest
to determine whether such an S. pombe Rap1 has one
or two Myb domains. ScRap1p has two Myb domains
and binds to telomeres through a direct interaction with
the telomeric DNA, while human Rap1 has a single Myb
motif and has no known telomeric DNA binding activity.
Thus, either scRap1p has gained a Myb domain or
hRap1 has lost one. Determination of the telomeric DNA
binding activity and the number of Myb domains in Rap1
in S. pombe or another fungus could provide insight
into this issue. It is of obvious interest to establish the
function of the single Myb motif in hRap1.
The genome of S. cerevisiae encodes one protein with
a TRF-like Myb domain, the TTAGGG repeat binding
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protein Tbf1p (Brigati et al., 1993; Bilaud et al., 1996).
Tbf1p has not been ascribed a function at telomeres so
far. It is unlikely that Tbf1p is a remnant of the budding
yeast TRF gene since Tbf1p lacks a TRFH domain and
an S. pombe Tbf1p ortholog is reported in the database.
Why does S. cerevisiae lack the TRF class of telomeric
proteins? One possibility is that during the evolution of
the budding yeasts, including S. cerevisiae, K. lactis,
and several Candida species, the telomeric DNA sequence may have been altered such that the TRF component could no longer bind to the telomeric repeat
array. A mutation in the telomerase RNA template could
have caused this alteration, and binding of Rap1 to the
new version of the telomeric DNA might have rescued
the potential lethality of this change (McEachern and
Blackburn, 1995; Krauskopf and Blackburn, 1996). An
alternative scenario is that loss of the TRF gene resulted
in selection of yeasts with specific compensatory mutations in their telomerase RNA template gene that allowed
Rap1 to bind to telomeric DNA independently.
Perusal of the large collection of available telomeric
DNA sequences indicates that the TTAGGG repeat of
present day vertebrate telomeres is the most pervasive
telomeric sequence in eukaryotes, also occurring in kinetoplastida, slime molds, and most branches of fungi
(e.g., Ustilago, Pneumocystis, Neurospora, and Aspergillus) (reviewed in Henderson, 1995) (Figure 7B). The
majority of other eukaryotes have telomeric sequences
that are closely related to the TTAGGG repeats, for
example TAGGG in Giardia, TT[T/A]GGG in tomato,
TTAGGC in C. elegans, and TTGGGG in the ciliate Tetrahymena. Even the heterogenous telomeric repeat of S.
pombe was recently recognized as being composed of
a TTACAGG repeat motif (Hiraoka et al., 1998). Thus,
the last common ancestor of all eukaryotes most likely
carried TTAGGG repeats or a closely related sequence
at its telomeres. Budding yeast telomeric DNA represents a striking departure from the TTAGGG motif, containing telomeric repeats that are very different in length
and sequence (e.g., ACGGATTTGATTAGGTATGTGG
TGT in K. lactis [McEachern and Blackburn, 1994]). Possibly the precursor of the Hemiascomycetes suffered a
major change in the telomerase RNA template region
(see also discussion in Brun et al., 1997).
We propose a model for the evolution of the telomeric
complex in which the ancestral eukaryotic telomeres
were composed of TTAGGG repeats and bound a TRFlike protein as well as a Rap1-like factor. During the
evolution of S. cerevisiae and other budding yeasts, a
telomerase mutation may have caused a shift in the
telomeric sequence, resulting in loss of the tethering
function of the TRF module (or vice versa). In agreement,
TRF1 does not bind telomeric DNA from S. cerevisiae
(Zhong et al., 1992). The optimal binding site for current
day human TRF1 contains two (overlapping) copies of
the sequence YTAGGGTTR (Bianchi et al., 1999), a precise representation of the TTAGGG repeat array, and
minor changes in this sequence strongly inhibit TRF1
binding (Zhong et al., 1992; Hanish et al., 1994). The
DNA binding activity of scRap1 may have rescued cells
bearing telomeres containing Rap1 recognition sites.
Once telomere function became independent of TRFs,
divergence of the telomeric sequence could occur, as
long as the Rap1 binding sites were preserved. Indeed,

Rap1 sites appear to be the only common motif in the
highly diverged telomeric sequences of budding yeasts
(McEachern and Hicks, 1993; Krauskopf and Blackburn,
1996, 1998). The DNA binding activity of scRap1p is
also important for its role as a transcriptional regulator.
Although there is no indication that the ortholog of Rap1
described here has a similar function, it is not excluded
that mammals have a second ortholog of Rap1 with a
role in gene expression.
Experimental Procedures
Isolation of hRap1
A two-hybrid screen was carried out with the yeast reporter strain
L40 (Hollenberg et al., 1995; Bianchi et al., 1997), using the human
HeLa S3 matchmaker cDNA library (Clontech), and a LexA-fused
hTRF2 cDNA as a bait. The TRF2 fusion contained an unintended
frame shift mutation leading to a TRF2 protein with 444 aa that is
mutated from aa 389. The hRap1 two-hybrid cDNA clone (aa positions 200 to 399, see Figure 1A) resulting from this screen was used
as probe on a cDNA library made from a human breast cancer cell
line (MDA) (Kratzschmar et al., 1996), yielding 26 positive clones.
Coupled in vitro transcription/translation of the largest cDNA (M50–
27MDA6–1) yielded a protein with an apparent MW of 63 kDa and
its sequence (GenBank accession number: AF262988) encoded a
predicted ORF of 399 aa.
Two-Hybrid Assays
The LexA-TRF2 full-length fusion was generated by inserting a PCR
fragment encoding TRF2 aa 2–389 into pBTM116 (Bartel et al., 1993)
at the EcoRI site, followed by replacement of the C-terminal half of
this clone by a NarI/BamHI fragment of TRF2 encoding aa 31–501.
Additional LexA-TRF2 fusions were generated by PCR amplification
of sequences encoding the indicated amino acids from the LexATRF2 full-length clone followed by insertion into the polylinker region
of pBTM116. GAD-TRF2 hybrid was generated by cloning the LexATRF2 StuI/BamHI fragment into pACT2 (Clontech). The LexA-hRap1
fusions were generated by PCR amplification using the hRap1 cDNA
(M50–27MDA6–1) followed by insertion into the BamHI site of
pBTM116. GAD-hRap1 fusions were generated similarly in pACT2.
The LexA-fused full-length hTRF1 (Smith et al., 1998) and the original
two-hybrid clone of hRap1 (M50–27) were used for testing interaction between TRF1 and hRap1. Expression of fusion proteins was
verified by Western blotting using anti-LexA or anti-GAD monoclonal
antibodies (Clontech).
Two-hybrid experiments were performed in the yeast strain L40.
␤-galactosidase activities were measured according to Clontech
MATCHMAKER library protocol. The average value of three individual transformants for each set of plasmid constructs is reported.
Values from individual transformants differed by ⬍30% from the
average.
Recombinant hRap1 and Generation of hRap1 Antibodies
N-terminally [His]6-tagged full-length hRap1 protein was expressed
in insect cells using the Bac-To-Bac Expression System (Monsato
Corporate Research). The recombinant hRap1 protein was purified
and used to immunize NZW rabbits (Covance). The resulting immune
serum, Ab 765, was affinity purified using hRap1 coupled to sulfolink
gel (Pierce). Peptides hRap1–211 (NH2-RKAEEDPEAADSGEPQNKR
TPDLPEC-COOH) starting at aa 211 and hRap1–283 (NH2-DPP
TPEEDSETQPDEEEEEEEEKVSC-COOH) starting at aa 283 of hRap1
were synthesized (BioSynthesis, Lewisville, TX), conjugated to KLH
(Pierce, Rockford, IL), and used to immunize NZW rabbits (Covance).
The resulting immune sera, Ab 666 (against hRap1-211) and Ab
664 (against hRap1-283), were affinity purified against sulfolink gel
(Pierce) bound peptides (hRap1-211and hRap1-283 respectively)
using standard procedures (Harlow and Lane, 1988).
Immunofluorescence and Metaphase Chromosome Spread
Preparation of metaphase chromosome spreads and indirect fluorescence techniques are described in Chong et al., 1995. In brief,
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HeLaI.2.11 cells (van Steensel et al., 1998) were washed in phosphate-buffered saline (PBS), fixed in 2% formaldehyde in PBS for
10 min, and permeabilized with 0.5% Nonidet P-40 in PBS for 10
min. To prepare metaphase chromosome spread, HeLa I.2.11 cells
were treated with colcemid (0.1 g/ml, 90 min), harvested by trypsinization, washed with serum and PBS, hypotonically swollen in 10
mM Tris (pH 7.4), 10 mM NaCl, and 5 mM MgCl2 (37⬚C, 15 min), and
sedimented onto cover slips for 15 s at 3000 rpm in a Sorvall
RT6000B tabletop centrifuge. Chromosome spreads were immediately fixed and permeabilized as described above. To examine the
hRap1 localization in interphase HeLa1.2.11 cells transfected with
hTRF2⌬B⌬M, cells were washed with PBS, extracted with Triton X-100
buffer (0.5% Triton X-100, 20 mM HEPES [pH 7.9], 50 mM NaCl, 3
mM MgCl2, and 300 mM sucrose) for 10 min, washed with PBS
twice, fixed with 3% formaldehyde, 2% sucrose in PBS for 10 min,
permeabilized with Triton X-100 buffer for 10 min, washed with PBS
twice followed by antibody staining. Most nucleoplasmic proteins
are extracted in this method. Residual signals represent predominantly DNA bound proteins.
Endogenous hRap1 was detected with polyclonal antibodies 765
and 666 (see above). TRF1 was detected with polyclonal mouse
anti-TRF1 antibody (Ab 3, S. Smith and T. d. L., unpublished data),
and TRF2 was detected with polyclonal mouse anti-TRF2 antibody
(Ab 2, X.-D. Zhu and T. d. L., unpublished data). In untransfected
HeLa1.2.11 cells, rabbit antibodies were detected with fluorescein
isothiocyanate (FITC)-conjugated donkey-anti-rabbit antibodies
(Jackson ImmunoResearch) and mouse antibodies were detected
with tetramethyl rhodamine isothiocyanate (TRITC)-conjugated
donkey anti-mouse antibodies (Jackson ImmunoResearch). In HeLa
1.2.11 cells transfected with hTRF2⌬B⌬M, rabbit antibodies were detected with tetramethyl rhodamine isothiocyanate (TRITC)-conjugated donkey-anti-rabbit antibodies (Jackson ImmunoResearch)
and mouse antibodies were detected with fluorescein isothiocyanate (FITC)-conjugated donkey anti-mouse antibodies (Jackson ImmunoResearch). DNA was stained with 4⬘, 6-diamidino-2-phenylindole (DAPI). Micrographs were recorded on a Zeiss Axioplan II
microscope with a Photometrics Sensys camera using IP Lab program (for metaphase chromosome spread experiment) or with a
Hammamatsu C4742–95 camera using Open Lab program (for other
IF experiments). IP lab images were noise filtered, corrected for
background, and merged using Adobe PhotoShop.
Cell Extracts and Western Blotting
Cells grown to semiconfluence on 15 cm dishes were trypsinized,
washed with media, harvested by centrifugation, washed with icecold PBS twice, and incubated with buffer C (van Steensel et al.,
1998) on ice for 30 min. The extract was cleared by centrifugation
for 10 min in an Eppendorf microfuge at 14,000 g at 4⬚C and the
supernatant was frozen in liquid nitrogen and stored at ⵑ80⬚C. Protein content of extracts was measured using the Bradford assay
(BioRad, Hercules, CA) using bovine serum albumin as a standard.
Proteins (65 g) were separated on 8% SDS-polyacrylamide gels
and transferred to nitrocellulose membrane by electrophoresis. Ponceau S-staining confirmed equal loading of the samples. Blots were
preincubated in 10% nonfat milk in PBS containing 0.5% Tween 20
for 30 min. All subsequent steps were carried out in 0.1% nonfat
dry milk powder and 0.1% Tween 20 in PBS. Blots were incubated
for 12–16 hr at 4⬚C with anti-hRap1 antibody 765, followed by three
10 min washing steps. Subsequently, blots were incubated for 30
min with horseradish peroxidase-conjugated donkey-anti-rabbit antibody (Amersham) and washed four times for 5 min each. Blots
were then rinsed with PBS followed by H2O. Bound antibody was
detected using the enhanced chemiluminescence kit (Amersham).
Bandshift Assays
Purified baculovirus-expressed, [His]6-tagged hRap1 and TRF2 proteins were used for bandshift assays. Binding reactions (in 4% Glycerol, 0.5 g E. coli DNA, 20 mM Glycine-KOH [pH 9.0], 10 mM DTT,
and 50 ng ␤-casein per 20 l) were incubated at 4⬚C for 30 min and
run on a 0.6% agarose gel in 0.1⫻ TBE at 4⬚C. Gels were dried onto
DE81 paper and analyzed by autoradiography or by exposure on a
Phosphorimager. DNA probes were prepared as described previously (Zhong et al., 1992). In brief, the HindIII/Asp718 fragment

containing (TTAGGG)12 repeats was purified from pTH12 (Zhong et
al., 1992) and filled in with [␣-32P]dCTP and Klenow enzyme.
Tetracyclin Inducible Expression of hRap1 in HTC75 Cells
A Tetracyclin controlled expression vector of full-length hRap1 carrying an N-terminal FLAG epitope tag was created by PCR cloning
in pUHD10–3 (Gossen and Bujard, 1992). First, pUHD10–3-FLAG-5⬘
was generated by inserting paired oligos encoding a FLAG tag into
BamHI site of pUHD10–3. A fragment representing the complete
coding region of hRap1 was generated by PCR using Pfu-polymerase and the primer pair 5⬘-GCGCAGATCTGCGGAGGCGTTGGAT
TTG-3⬘ and 5⬘-GCGCGGATCCTTATTTCTTTCGAAATTCAATCCT-3⬘
and cloned into the BamHI site. The resulting plasmid was introduced into HTC75 as described previously (van Steensel et al., 1998)
and independent clonal cell lines (F lines) were isolated using cloning
cylinders. Growth conditions of the cells and methods to measure
telomere lengths were described previously (van Steensel and de
Lange, 1997).
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